Daniel O'Day

Retired U.S. Army Colonel Jack Jacobs, a Medal of Honor recipient and military strategy expert, discusses the U.S. military strikes on Iranian nuclear sites and potential repercussions for U.S.-Iran relations. Daniel O'Day, CEO of Gilead Sciences, shares insights on the FDA's approval of a groundbreaking injectable HIV prevention drug and its significance for public health. Both guests provide valuable perspectives on geopolitical tensions and innovations in healthcare, underscoring the interplay of politics and science.